U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022012

Expand all

COREG CR (CARVEDILOL PHOSPHATE)
10MG
Marketing Status: Prescription
Active Ingredient: CARVEDILOL PHOSPHATE
Proprietary Name: COREG CR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022012
Product Number: 001
Approval Date: Oct 20, 2006
Applicant Holder Full Name: WOODWARD PHARMA SERVICES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
COREG CR (CARVEDILOL PHOSPHATE)
20MG
Marketing Status: Prescription
Active Ingredient: CARVEDILOL PHOSPHATE
Proprietary Name: COREG CR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022012
Product Number: 002
Approval Date: Oct 20, 2006
Applicant Holder Full Name: WOODWARD PHARMA SERVICES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
COREG CR (CARVEDILOL PHOSPHATE)
40MG
Marketing Status: Prescription
Active Ingredient: CARVEDILOL PHOSPHATE
Proprietary Name: COREG CR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022012
Product Number: 003
Approval Date: Oct 20, 2006
Applicant Holder Full Name: WOODWARD PHARMA SERVICES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
COREG CR (CARVEDILOL PHOSPHATE)
80MG
Marketing Status: Prescription
Active Ingredient: CARVEDILOL PHOSPHATE
Proprietary Name: COREG CR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022012
Product Number: 004
Approval Date: Oct 20, 2006
Applicant Holder Full Name: WOODWARD PHARMA SERVICES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top